Curia – Origgio, Italy
API and intermediate manufacturing through chemical synthesis, with hydrogenation to 14 m³.
Curia’s Origgio facility develops and manufactures active pharmaceutical substances and intermediates through chemical synthesis. The site pairs 549 m³ of synthesis capacity and reactors up to 16,000 L with specialist depth in hydrogenation, boronic acid chemistry, lithiation and carbonylation, under FDA, AIFA and PMDA inspection.